Is Alzheimer’s a neurocognitive disorder

Yes. In the DSM-5, the diagnostic manual used by mental health and many medical professionals, Alzheimer’s disease is listed as one of the causes of neurocognitive disorder. A clinician may diagnose “mild neurocognitive disorder due to Alzheimer’s disease” or “major neurocognitive disorder due to Alzheimer’s disease,” depending on how much the person’s thinking has changed and how much it affects independence.

“Neurocognitive disorder” is essentially the manual’s modern umbrella term for conditions once described mainly as dementia, plus the milder stage that comes before it. The name describes the problem, a decline in cognition with a brain-based cause, while “due to Alzheimer’s disease” names the reason behind it. Alzheimer’s itself remains a neurodegenerative brain disease.

Why the Manual Changed Its Language

Earlier editions relied heavily on the word dementia. When the DSM-5 was published in 2013, it introduced “major neurocognitive disorder” and “mild neurocognitive disorder.” There were a few reasons. The word dementia can carry stigma, it does not fit younger people with brain injuries or HIV-related thinking problems very well, and it left no clear category for people whose changes were real but not yet disabling. The new framework recognizes a spectrum, from subtle decline to severe impairment.

Doctors and families still use “dementia” widely, and that is perfectly acceptable. In everyday conversation, major neurocognitive disorder and dementia mean much the same thing.

Mild vs. Major: The Key Difference

The dividing line between the two categories is independence in daily life. Both involve a measurable decline from a person’s previous level in one or more areas of thinking, such as memory, attention, language, planning, perception or social understanding.

Clinicians usually measure decline with standardized cognitive testing and compare it with what would be expected for the person’s age and education. Just as important is the report of a family member or close friend, who can describe how everyday abilities, such as cooking, managing appointments or using a phone, have changed over months or years.

How Doctors Link It to Alzheimer’s

To say a neurocognitive disorder is “due to Alzheimer’s disease,” the clinician looks for a specific profile. The DSM-5 describes “probable” and “possible” Alzheimer’s. In general, the diagnosis is more confident when:

• the decline begins gradually and progresses steadily;
• memory and learning are clearly affected, usually with at least one other area of thinking;
• there is no strong evidence of another cause, such as major strokes, Lewy body disease or another brain condition;
• there is evidence of a genetic cause in the family history or testing, or biomarker evidence of Alzheimer’s brain changes.

Biomarker tests, including amyloid PET scans, spinal fluid analysis and newer blood tests, have made it easier to confirm Alzheimer’s biology during life. Research frameworks from the National Institute on Aging and the Alzheimer’s Association now define the disease by these biological changes, while clinical manuals focus on symptoms and function.

Other Causes of Neurocognitive Disorder

Alzheimer’s is the most common cause, but it is not the only one. The DSM-5 also lists neurocognitive disorder due to vascular disease, Lewy body disease, frontotemporal degeneration, Parkinson’s disease, Huntington’s disease, traumatic brain injury, HIV infection, prion disease, substance or medication use, other medical conditions and multiple causes. Many older adults have mixed causes, especially Alzheimer’s combined with vascular changes.

Identifying the cause matters because each condition has its own pattern, outlook and treatment considerations. Some medications that help in one type can be risky in another, for example in Lewy body disease, where sensitivity to certain antipsychotic drugs is a known concern.

What a Diagnosis Means in Practice

Receiving a neurocognitive disorder diagnosis is the start of a plan, not the end of the conversation. For someone in the mild stage, that plan may include treating blood pressure and hearing loss, staying physically and socially active, reviewing medications and discussing whether newer early-stage treatments are appropriate. For someone with major neurocognitive disorder, the focus broadens to safety at home, driving decisions, legal and financial planning and support for caregivers.

Specifiers in the DSM-5 also allow clinicians to note whether behavioral symptoms, such as agitation, psychotic symptoms or mood changes, are present, and to rate severity as mild, moderate or severe. That detail helps the whole care team stay on the same page.

Frequently Asked Questions

Is mild neurocognitive disorder the same as MCI?

They overlap closely. MCI is the term most often used in neurology and research, while mild neurocognitive disorder is the DSM-5 label. Both describe changes greater than expected for age that do not yet take away independence.

Does a neurocognitive disorder diagnosis mean it is psychiatric?

No. The DSM-5 includes neurocognitive disorders because they affect thinking and behavior, but their causes are medical and neurological, like Alzheimer’s.

Where can families learn more?

The Alzheimer’s Association and the National Institute on Aging both offer free, plain-language information about diagnosis, stages and care planning, as well as helplines and local support.

From Diagnosis Codes to Daily Brain Care

Terms like “neurocognitive” can make brain health sound distant and clinical. Yet much of what keeps the mind feeling clear happens in ordinary moments: a good night’s sleep, a walk outdoors, a meal that agrees with you. Scientists are paying more and more attention to one of those everyday systems in particular, the gut, and the gut–brain axis has become an active and growing field of research.

Synaptigen brings that idea into a simple daily routine. It is a brain-health formula in tablet form, made to support memory, focus and mental clarity. Every tablet combines the probiotics Lactobacillus paracasei, Lactobacillus reuteri and Bifidobacterium lactis BL-04 with inulin, a prebiotic fiber that feeds helpful gut bacteria. Strawberry extract, peppermint extract and tricalcium phosphate complete a short, thoughtfully chosen ingredient list.

People appreciate that Synaptigen feels effortless. It is natural, non-GMO and contains no stimulants, so there is no racing heart or afternoon crash. Take your tablet, and that is it. Synaptigen is a memory-support supplement intended for use alongside your doctor’s recommendations, never as a substitute for them, so it fits neatly into a well-rounded plan for your health.

There has rarely been a better time to start. The top-value choice is 6 bottles, 3 bottles plus 3 free, at only $49 per bottle, with free shipping and three bonus e-books: Deep Sleep Blueprint, Sharp Mind in 7 Days, and 10 Proven Ways to Learn Faster and Boost Memory. Prefer to start smaller? Pick 3 bottles (2 plus 1 free) at $69 per bottle, or 2 bottles at $79 per bottle.

It also pairs naturally with the other brain-friendly choices you may already be making, like staying active, keeping in touch with friends and protecting your sleep. Synaptigen simply adds one more easy, consistent step that takes seconds and travels anywhere you go.

Each Synaptigen order includes a 180-day, 100% money-back guarantee, so you can try it with complete peace of mind. Six months is plenty of time to make it a habit and judge the experience for yourself.

Make daily brain care as easy as one small tablet. Start Synaptigen today and lock in the 6-bottle savings, free shipping and the 180-day guarantee before this offer disappears.